| Literature DB >> 35884759 |
Kaixi Liu1, Yanan Song1, Yi Yuan2, Zhengqian Li1, Xiaoxiao Wang3, Wenchao Zhang2, Yue Li1, Xinning Mi1, Dengyang Han1, Yulan Rong1, Xiangyang Guo1, Geng Wang2.
Abstract
(1) Background: Previous evidence demonstrates that tight glycemic control and good physical function could reduce the risk of delirium. This study aimed to investigate whether the occurrence of postoperative delirium (POD) in older hip fracture surgery patients is associated with preoperative glycemic control factors or pre-injury physical performance. (2)Entities:
Keywords: glycemic control; hip fracture; physical performance; postoperative delirium; type 2 diabetes mellitus
Year: 2022 PMID: 35884759 PMCID: PMC9317912 DOI: 10.3390/brainsci12070951
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Figure 1Study flow chart.
Baseline features and preoperative characteristics.
| Variable | Non-POD | POD ( |
|
|---|---|---|---|
|
| |||
|
| 68 (26.46%) | 16 (30.77%) | 0.524 |
|
| 79 (73, 83) | 81 (75, 85) | 0.146 |
|
| 23.44 (21.12, 26.20) | 23.67 (22.09, 26.19) | 0.524 |
|
| 49 (19.07%) | 11 (21.15%) | 0.729 |
|
| 23 (8.95%) | 7 (13.46%) | 0.316 |
|
| 9 (4, 12) | 9 (6, 12) | 0.628 |
|
| 26 (23, 28) | 25.5 (21, 28) | 0.065 |
|
| 172 (66.9%) | 30 (57.7%) | 0.202 |
|
| 6 (6, 6) | 6 (4, 6) | 0.237 |
|
| 3 (2, 4) | 4 (3, 5) | 0.003 |
|
| 0.667 | ||
|
| 4 (1.65%) | 0 (0%) | |
|
| 177 (68.78%) | 34 (65.38%) | |
|
| 76 (29.57%) | 18 (34.62%) | |
|
| |||
|
| 122 (110, 131) | 120 (105, 126) | 0.195 |
|
| 41.4 (39.4, 43.4) | 40.9 (39.0, 42.1) | 0.063 |
|
| 26 (10.12%) | 7 (13.46%) | 0.470 |
|
| 28 (10.89%) | 3 (5.77%) | 0.287 |
|
| 57 (22.18%) | 9 (17.31%) | 0.502 |
|
| 129 (59.19%) | 29 (55.77%) | 0.423 |
|
| |||
|
| 69 (26.85%) | 23 (44.23%) | 0.012 |
|
| 146 (56.81%) | 36 (69.23%) | 0.097 |
|
| 58 (22.57%) | 13 (25.00%) | 0.704 |
|
| 9 (3.50%) | 3 (5.77%) | 0.705 |
|
| 46 (17.90%) | 11 (21.15%) | 0.608 |
|
| 6 (2.33%) | 4 (7.69%) | 0.118 |
The categorical variables are expressed as n (%). Normal data are given as mean ± SD, whereas non-normal data are expressed as median (25th percentile, 75th percentile). BMI, body mass index; MMSE, Mini-Mental State Exam; ADL, activities of daily living; ACCI, age-adjusted Charlson comorbidity index; T2DM, type 2 diabetes mellitus.
Intra-operative data.
| Variable | Non-POD ( | POD ( |
|
|---|---|---|---|
|
| 95 (70, 123) | 81 (59, 145) | 0.499 |
|
| 0.001 | ||
|
| 124 (48.25%) | 20 (38.46%) | |
|
| 99 (38.52%) | 32 (61.54%) | |
|
| 34 (13.23%) | 0 (0%) | |
|
| 0.020 | ||
|
| 132 (51.36%) | 25 (48.08%) | |
|
| 30 (11.67%) | 11 (21.15%) | |
|
| 64 (24.90%) | 16 (30.77%) | |
|
| 31 (12.06%) | 0 (0%) | |
|
| 90 (75, 110) | 90 (79, 116) | 0.454 |
|
| 60 (40, 80) | 60 (38, 90) | 0.822 |
SA, spinal anesthesia; GA, general anesthesia; THA, total hip replacement arthroplasty.
Postoperative data.
| Variable | Non-POD | POD ( |
|
|---|---|---|---|
|
| 117 (45.53%) | 27 (51.92%) | 0.399 |
|
| 30 (11.67%) | 5 (9.62%) | 0.669 |
|
| 14 (5.45%) | 6 (11.54%) | 0.187 |
|
| 11 (4.28%) | 8 (15.38%) | 0.006 |
|
| 17 (6.61%) | 2 (3.85%) | 0.659 |
|
| 16 (6.23%) | 2 (3.85%) | 0.731 |
|
| 11 (4.28%) | 4 (7.69%) | 0.49 |
|
| 10 (3.89%) | 3 (5.77%) | 0.813 |
|
| 2 (2, 3) | 3 (2, 5) | <0.001 |
Glycemic control factors.
| Variable | Non-POD | POD ( |
|
|---|---|---|---|
|
| 7.9 (6.6, 10.1) | 7.5 (6.65, 8.9) | 0.156 |
|
| 5.8 (5.4, 6.5) | 6.0 (5.5, 6.7) | 0.313 |
|
| 37.9 (10.5, 71.32) | 28.5 (8.96, 58.27) | 0.245 |
|
| 188 (73.15%) | 29 (55.77%) | |
|
| 7.4 (6.8, 8.8) | 7.1 (5.9, 7.9) | 0.084 |
|
| 5.6 (5.3, 5.9) | 5.7 (5.32, 6.0) | 0.746 |
|
| 22.7 (8.8, 41.2) | 14.4 (6.66, 28.6) | 0.112 |
|
| 90 (47.87%) | 14 (48.28%) | 0.834 |
|
| 69 (26.85%) | 23 (44.23%) | |
|
| 10.6 (8.7, 13.6) | 8.4 (7.5, 10.1) | 0.015 |
|
| 6.9 (6.3, 8.0) | 6.7 (6.0, 7.5) | 0.285 |
|
| 37.9 (10.5, 71.3) | 28.5 (9.0, 58.3) | 0.245 |
|
| 19 (27.54%) | 5 (21.74%) | 0.677 |
|
| 5 (7.24%) | 1 (4.35%) | 1.000 |
|
| 8 (5, 12) | 10 (9, 12) | 0.119 |
|
| 15 (21.74%) | 3 (13.04%) | 0.544 |
|
| 4 (5.80%) | 3 (13.04%) | 0.496 |
FBG, fasting blood glucose; HbA1c, glycosylated hemoglobin, type A1C; GG, glycemic gap; T2DM, type 2 diabetes mellitus; SIH, stress-induced hyperglycemia; DPN, diabetic peripheral neuropathy; DPVD, diabetic peripheral vascular disease. a Data were extracted from non-T2DM patients; b data were extracted from T2DM patients.
Per-injury self-reported physical performance *.
| Variable | Non-POD | POD ( |
|
|---|---|---|---|
|
| 1000 (500, 2000) | 500 (200, 1000) | <0.001 |
|
| 2 (1, 4) | 1 (0, 2) | <0.001 |
|
| 61 (23.74%) | 23 (44.23%) | 0.002 |
|
| 0.001 | ||
|
| 25 (10.00%) | 12 (24.49%) | |
|
| 95 (38.00%) | 24 (48.98%) | |
|
| 130 (52.00%) | 13 (26.53%) |
* Physical performance was assessed by a geriatrician in Beijing Jishuitan hospital based on the patient’s general condition.
Univariate logistic analysis.
| Variable | B | SE | Walds |
| OR [95% CI] |
|---|---|---|---|---|---|
|
| −0.211 | 0.332 | 0.405 | 0.525 | 0.810 [0.422, 1.552] |
|
| 0.031 | 0.023 | 1.820 | 0.177 # | 1.031 [0.986, 1.079] |
|
| 0.030 | 0.043 | 0.489 | 0.484 | 1.030 [0.948, 1.120] |
|
| 0.130 | 0.375 | 0.120 | 0.729 | 1.139 [0.546, 2.374] |
|
| 0.459 | 0.461 | 0.995 | 0.320 | 1.583 [0.641, 3.909] |
|
| 0.014 | 0.028 | 0.479 | 0.632 | 1.014 [0.959, 1.072] |
|
| −0.061 | 0.027 | 5.111 | 0.024 # | 0.941 [0.892, 0.992] |
|
| −0.192 | 0.092 | 4.365 | 0.037 # | 0.825 [0.689, 0.988] |
|
| 0.268 | 0.090 | 8.902 | 0.003 # | 1.307 [1.096, 1.559] |
|
| 0.232 | 0.322 | 0.518 | 0.472 | 1.261 [0.671, 2.370] |
|
| 0.001 | 0.001 | 2.414 | 0.120 # | 1.001 [1.000,1.002] |
|
| 0.000 | 0.005 | 0.009 | 0.925 | 1.000 [0.991, 1.010] |
|
| −0.003 | 0.005 | 0.291 | 0.590 | 0.997 [0.987, 1.007] |
|
| −0.012 | 0.008 | 2.656 | 0.103 # | 0.988 [0.973, 1.003] |
|
| −0.087 | 0.046 | 3.658 | 0.056 # | 0.917 [0.838, 1.002] |
|
| 0.537 | 0.326 | 2.715 | 0.099 # | 1.711 [0.903, 3.239] |
|
| 0.134 | 0.353 | 0.144 | 0.704 | 1.144 [0.572, 2.286] |
|
| 0.523 | 0.685 | 0.583 | 0.445 | 1.687 [0.441, 6.456] |
|
| 0.193 | 0.377 | 0.263 | 0.608 | 1.213 [0.580, 2.538] |
|
| 1.249 | 0.664 | 3.532 | 0.060 # | 3.486 [0.948, 12.821] |
|
| 0.771 | 0.313 | 6.072 | 0.014 # | 2.161 [1.171, 3.988] |
|
| 0.031 | 0.032 | 0.991 | 0.319 | 1.032 [0.970, 1.098] |
|
| −0.616 | 0.684 | 0.810 | 0.368 | 0.540 [0.141, 2.066] |
|
| 0.891 | 0.805 | 1.224 | 0.269 | 2.437 [0.503,11.818] |
|
| 0.283 | 0.527 | 0.288 | 0.592 | 1.327 [0.472, 0.731] |
|
| 0.013 | 0.059 | 2.438 | 0.118 # | 0.913 [0.814,1.024] |
|
| 0.094 | 0.329 | 0.156 | 0.692 | 1.139 [0.598, 2.171] |
|
| −0.798 | 0.222 | 12.908 | 0.000 # | 0.450 [0.292, 0.696] |
|
| −0.040 | 0.015 | 7.264 | 0.007 # | 0.961 [0.933, 0.989] |
|
| 0.971 | 0.320 | 9.217 | 0.002 # | 2.639 [1.411, 4.939] |
|
| −0.386 | 0.109 | 12.584 | 0.000 # | 0.680 [0.550, 0.841] |
BMI, body mass index; MMSE, Mini-Mental State Exam; ADL, activities of daily living; ACCI, age-adjusted Charlson comorbidity index; T2DM, type 2 diabetes mellitus; DPN, diabetic peripheral neuropathy; DPVD, diabetic peripheral vascular disease; FBG, fasting blood glucose; HbA1c, glycosylated hemoglobin, type A1C; #, p < 0.2.
Multivariable logistic analysis.
| Variable | B | SE | Wals |
| OR [95% CI] |
|---|---|---|---|---|---|
|
| −0.063 | 0.330 | 3.654 | 0.056 | 0.939 [0.881, 1.002] |
|
| 0.239 | 0.115 | 4.319 | 0.038 | 1.270 [1.014, 1.592] |
|
| 1.296 | 0.405 | 10.215 | 0.001 | 3.654 [1.651, 8.089] |
|
| −0.218 | 0.077 | 8.076 | 0.004 | 0.804 [0.692, 0.935] |
|
| −0.344 | 0.117 | 8.666 | 0.003 | 0.709 [0.564, 0.891] |
MMSE, Mini-Mental State Exam; ACCI, age-adjusted Charlson comorbidity index; T2DM, type 2 diabetes mellitus; FBG, fasting blood glucose.
Figure 2Predictors of POD with OR and 95% CI. MMSE: Mini-Mental State Exam; ACCI: age-adjusted Charlson comorbidity index; T2DM: type 2 diabetes mellitus; FBG, fasting blood glucose.
Figure 3AUROC curve predicted by Model 1, 2, and 3.